Magnetar Financial’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-714,500
| Closed | -$7.05K | – | 1836 |
|
|
2022
Q2 | $7.05K | Sell |
714,500
-63,200
| -8% | -$624 | 0.07% | 236 |
|
|
2022
Q1 | $7.67M | Sell |
777,700
-7,209
| -0.9% | -$71.1K | 0.08% | 238 |
|
|
2021
Q4 | $7.87M | Sell |
784,909
-18,491
| -2% | -$185K | 0.08% | 258 |
|
|
2021
Q3 | $8.03M | Hold |
803,400
| – | – | 0.08% | 257 |
|
|
2021
Q2 | $8.07K | Buy |
803,400
+600
| +0.1% | +$6 | 0.08% | 256 |
|
|
2021
Q1 | $7.92M | Buy |
+802,800
| New | +$7.92M | 0.08% | 239 |
|